JPH06245793A - Method for detecting helicobacter pylori - Google Patents
Method for detecting helicobacter pyloriInfo
- Publication number
- JPH06245793A JPH06245793A JP5036661A JP3666193A JPH06245793A JP H06245793 A JPH06245793 A JP H06245793A JP 5036661 A JP5036661 A JP 5036661A JP 3666193 A JP3666193 A JP 3666193A JP H06245793 A JPH06245793 A JP H06245793A
- Authority
- JP
- Japan
- Prior art keywords
- helicobacter pylori
- detecting
- formula
- present
- detecting helicobacter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
(57)【要約】
【目的】 特異的かつ簡便にヘリコバクター ピロリを
検出する方法を提供すること。
【構成】 ヘリコバクター ピロリを含有する試料を酸
メタノリシスし、式
(式中、nは5または7である。)で表される11−メ
トキシ脂肪酸メチルエステルを同定することからなるヘ
リコバクター ピロリの検出方法。(57) [Summary] [Objective] To provide a method for specifically and simply detecting Helicobacter pylori. [Structure] A sample containing Helicobacter pylori was subjected to acid methanolysis, (In the formula, n is 5 or 7.) A method for detecting Helicobacter pylori, which comprises identifying 11-methoxy fatty acid methyl ester represented by the formula.
Description
【0001】[0001]
【産業上の利用分野】本発明は、微生物の検出方法に関
し、更に詳しくはヘリコバクター ピロリ(Helic
obacter pylori;以下、Hpと称するこ
とがある。)の検出方法に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for detecting microorganisms, and more particularly to Helicobacter pylori (Helic).
bacterium pylori; hereinafter sometimes referred to as Hp. ) Detection method.
【0002】[0002]
【従来の技術】Hpは、ヒト活動性慢性胃炎の粘膜から
高率に検出され、猿胃内に接種されると定着してヒト類
似の活動性胃炎を発生することなどから、胃病変に密接
に関連することが知られている。近年は、この細菌が胃
癌発生に関する幾つかの因子の一つにも挙げられている
[Am.J.Gastroenterol.,第84
巻,第775〜781(1989年),Cancer,
第66巻,第2569〜2574(1990年)な
ど]。2. Description of the Related Art Hp is detected in the mucous membrane of human active chronic gastritis at a high rate, and when it is inoculated into the monkey stomach, Hp colonizes and produces active gastritis similar to human. It is known to be related to. Recently, this bacterium has been listed as one of several factors involved in the development of gastric cancer [Am. J. Gastroenterol. , 84th
Volume 775-781 (1989), Cancer,
66, 2569-2574 (1990), etc.].
【0003】従来、Hpの同定は、胃粘膜より採取した
組織を培養し、これをWarthium Starry
の銀染料、ギムザ、ヘマトキシリン、エオシンあるいは
アクリジンオレンジのいずれかにて染色ののち、顕微鏡
検査によって確認される。また、Hpは大量のウレアー
ゼを産生するため、ウレアーゼの存在を探知することに
よってHpを検出する方法が検討されている。さらに、
胃炎、胃・十二指腸潰瘍、胃癌などの胃疾患、就中胃癌
患者で疫学的にHpの感染を明らかにするには、血清学
的に抗体の存在を証明する方法が採用されている。[0003] Conventionally, the identification of Hp was carried out by culturing a tissue collected from the gastric mucosa, and then culturing the tissue.
Confirmed by microscopic examination after staining with any of the silver dyes of Giemsa, Hematoxylin, Eosin or Acridine Orange. Since Hp produces a large amount of urease, a method of detecting Hp by detecting the presence of urease has been studied. further,
In order to clarify epidemiologic Hp infection in patients with gastritis, gastric / duodenal ulcer, gastric cancer such as gastric cancer, and especially gastric cancer, a method of demonstrating the presence of antibodies serologically has been adopted.
【0004】しかしながら、直接染色法、ウレアーゼ活
性法はいずれも長時間を要し、かつ満足できる感度及び
特異性はいまだ示されていない。抗体の存在を証明する
方法においても、Hpの抗原性は極めて多用で、現在既
に開発されている欧米のキットを用いても充分な特異性
が得られず、数%の偽陰性と30%近くの偽陽性が発現
する。However, both the direct staining method and the urease activity method require a long time, and satisfactory sensitivity and specificity have not yet been shown. Even in the method of proving the existence of antibodies, the antigenicity of Hp is extremely extensively used, and even with the Western kits that have already been developed, sufficient specificity cannot be obtained. False positives are expressed.
【0005】[0005]
【発明が解決しようとする課題】本発明の目的は、特異
的かつ簡便にHpを検出する方法を提供することにあ
る。An object of the present invention is to provide a method for specifically and simply detecting Hp.
【0006】[0006]
【課題を解決するための手段】本発明者は、上記目的に
鑑みHpの産生物質について鋭意検討した結果、Hpよ
り11−メトキシ脂肪酸が産生されることを初めて見出
した。これまでメトキシ脂肪酸はMycobacter
iumのある種の細菌にのみ発見されていたが、Hpの
場合のメトキシ基の位置はMycobacterium
のそれとは異なるものであった。従って11−メトキシ
脂肪酸の存在はHp分類学上の特性を示している。Means for Solving the Problems The present inventor has, as a result of diligent studies on a substance producing Hp in view of the above-mentioned object, found for the first time that 11-methoxy fatty acid is produced from Hp. So far, methoxy fatty acid has been Mycobacterium
It was found only in certain bacteria of ium, but the position of the methoxy group in Hp is Mycobacterium
It was different from that. Thus, the presence of 11-methoxy fatty acids is characteristic of Hp taxonomy.
【0007】本発明はかかる知見に基づいて完成された
ものであり、以下本発明を説明する。本発明は、ヘリコ
バクター ピロリを含有する試料を酸メタノリシスし、
式The present invention has been completed based on such findings, and the present invention will be described below. The present invention is acid methanolysis of a sample containing Helicobacter pylori,
formula
【0008】 [0008]
【0009】(式中、nは5または7である。)で表さ
れる11−メトキシ脂肪酸メチルエステルを同定するこ
とからなるヘリコバクター ピロリの検出方法である。
以下、順を追って本発明を詳細に説明する。本発明にお
いて、HPを含有する試料とは、高等動物の胃粘膜、胃
液などであり、これらは場合により培養される。培養
は、Hpを増殖するものであればいずれの方法でもよ
い。たとえば、深見の方法[検査と技術,第17巻,第
1389〜1394頁(1989年)]、brucel
la寒天培地を用いる方法などがある。次いで、培養物
から、常法により、培養した細菌を集め、洗浄、遠心分
離して菌体を得ることができる。A method for detecting Helicobacter pylori, which comprises identifying an 11-methoxy fatty acid methyl ester represented by the formula (n is 5 or 7).
Hereinafter, the present invention will be described in detail step by step. In the present invention, the sample containing HP is gastric mucosa, gastric juice and the like of higher animals, which are optionally cultured. The culture may be performed by any method as long as it can grow Hp. For example, Fukami's method [Inspection and Technology, Volume 17, 1389-1394 (1989)], Brucel
There is a method using a la agar medium. Then, the cultured bacteria can be collected from the culture by a conventional method, washed and centrifuged to obtain bacterial cells.
【0010】本発明において、酸メタノリシスする試料
は、その脂質成分を抽出したものを用いるのが好まし
い。脂質を抽出するためには、たとえば、胃液を適宜な
溶媒によって抽出する方法、前述の菌体をクロロホルム
−メタノールの混合溶媒を用いて室温に一晩放置するな
ど方法などによって行うことができるが、本発明はこれ
に限定されるものではない。抽出溶媒としては、上記以
外に塩化メチレン、酢酸エチル、エチルエーテル、テト
ラヒドロフラン、エタノールなどの脂質と反応しない溶
媒を単独または混合して用いることができる。抽出条件
は溶媒によっては加温することもあり、数分間〜数時間
行うこともある。In the present invention, it is preferable to use the extracted lipid component as the sample for acid methanolysis. In order to extract lipids, for example, a method of extracting gastric juice with an appropriate solvent, a method of leaving the above-mentioned cells at room temperature overnight using a mixed solvent of chloroform-methanol, etc. The present invention is not limited to this. As the extraction solvent, other than the above, solvents that do not react with lipids such as methylene chloride, ethyl acetate, ethyl ether, tetrahydrofuran, and ethanol can be used alone or in combination. The extraction conditions may be heating depending on the solvent, and may be for several minutes to several hours.
【0011】酸メタノリシスは、好ましくは5%無水メ
タノール−塩酸混合物を用い、60〜100℃で、1〜
4時間加熱または還流することによって行われる。酸メ
タノリシス後、通常の化学的手段と同様に、たとえばヘ
キサンなどの溶媒で抽出することによって脂肪酸メチル
エステルを含む粗生成物を得る。The acid methanolysis is preferably carried out using a 5% anhydrous methanol-hydrochloric acid mixture at 60 to 100 ° C.
It is carried out by heating or refluxing for 4 hours. After acid methanolysis, a crude product containing fatty acid methyl ester is obtained by extraction with a solvent such as hexane in the same manner as in ordinary chemical means.
【0012】なお、他のアルコールで酸アルコリシスす
ることが可能である。11−メトキシ脂肪酸メチルエス
テルの同定には、たとえばガス液体クロマトグラフィー
(GLC)、ガス・クロマトグラフィー質量分析(GC
−MS)、赤外線スペクトル、NMRなどの科学機器に
よる分析のほか、酵素法、化学反応分析法などが用いら
れるが、本発明はこれらの手段に限定されない。Acid alcoholysis can be carried out with other alcohols. For identification of 11-methoxy fatty acid methyl ester, for example, gas liquid chromatography (GLC), gas chromatography mass spectrometry (GC
-MS), infrared spectrum, analysis by scientific instruments such as NMR, as well as enzymatic method, chemical reaction analysis method and the like are used, but the present invention is not limited to these means.
【0013】[0013]
【発明の効果】本発明により、従来法に比べ極めて特異
的かつ簡便にHpを検出する方法が提供された。INDUSTRIAL APPLICABILITY The present invention provides a method for detecting Hp which is extremely specific and simple as compared with the conventional method.
【0014】[0014]
【実施例】以下、本発明を更に具体的に説明する。The present invention will be described in more detail below.
【0015】実施例 Hpの標準株(ATCC43504)を10%CO2,
10%O2,80%N2条件下、抗生物質を含まない10
%馬血清添加brucella寒天培地中37℃で5日
間培養した。培養した細菌を集め、生理食塩水で洗浄
し、15分間遠心分離(9×103g)して1.6gの
菌体を得た。EXAMPLE A standard strain of Hp (ATCC43504) was treated with 10% CO 2 ,
No antibiotics under 10% O 2 and 80% N 2 conditions 10
The cells were cultured at 37 ° C. for 5 days in brucella agar medium supplemented with% horse serum. The cultured bacteria were collected, washed with physiological saline, and centrifuged for 15 minutes (9 × 10 3 g) to obtain 1.6 g of bacterial cells.
【0016】混合比(体積/体積)2:1,1:1,
1:2のクロロホルム−メタノール混合物各50mlを
用いて、前記菌体を室温にて一晩放置して脂質の抽出を
行った。各抽出液を合わせて、回転エバポレーター中で
蒸発乾固し、次いでこれを蒸留水10ml中に懸濁し、
蒸留水に対して透析を行い、最終的に蒸発乾固物(粗脂
質)40mgを得た。このうち1mgについて、5%無
水メタノール−塩酸混合物1mlを用いて、100℃で
3時間かけてメタノリシスを行った。反応液をヘキサン
1.5mlを用いて抽出を3回行い、ヘキサン層を合わ
せ、窒素気流中で蒸発乾固した(検体1)。Mixing ratio (volume / volume) 2: 1, 1: 1,
Using 50 ml of each 1: 2 chloroform-methanol mixture, the cells were left overnight at room temperature to extract lipids. The extracts were combined and evaporated to dryness in a rotary evaporator, which was then suspended in 10 ml of distilled water,
It was dialyzed against distilled water to finally obtain 40 mg of a dried solid matter (crude lipid). Of this, 1 mg was subjected to methanolysis at 100 ° C. for 3 hours using 1 ml of a 5% anhydrous methanol-hydrochloric acid mixture. The reaction solution was extracted three times with 1.5 ml of hexane, the hexane layers were combined, and evaporated to dryness in a nitrogen stream (sample 1).
【0017】また、そのうち一部は、5:2:1(体積
比)のピリジン/ヘキサメチルジシラザン/トリメチル
クロロシランの混合物とともに60℃で20分間攪拌し
て、トリメチルシリル化を行った(検体2)。Some of them were subjected to trimethylsilylation by stirring with a mixture of 5: 2: 1 (volume ratio) of pyridine / hexamethyldisilazane / trimethylchlorosilane for 20 minutes at 60 ° C. (Sample 2). .
【0018】GLCおよびGC−MSによる同定;検体
1および検体2をヘキサンの0.1mlに溶解し、DB
−1溶融シリカカラム(0.25mm×25m,J&W
Scientific,California,U.
S.A.)にて180℃から250℃まで5℃/min
で昇温させてGLC分析した。Identification by GLC and GC-MS; Specimen 1 and Specimen 2 were dissolved in 0.1 ml of hexane, and DB
-1 Fused silica column (0.25mm × 25m, J & W
Scientific, California, U.S.A.
S. A. ) From 180 ℃ to 250 ℃ at 5 ℃ / min
The temperature was raised by and GLC analysis was performed.
【0019】検体1の分析結果を図1に示した。図1に
よれば、構造不明のピークAおよびBが見いだされた。
本ピークはトリメチルシリル化した検体2においては、
変化が見られなかった。The analysis result of the sample 1 is shown in FIG. According to FIG. 1, peaks A and B of unknown structure were found.
This peak is in trimethylsilylated sample 2,
No change was seen.
【0020】ピークはAおよびBについて、Shima
zu QP−1000(京都)質量分析計(Carri
er gas:N2)によりGC−MS分析を行った。
それぞれの結果を図2および図3に示した。AおよびB
のGC−MS分析結果は、これらが典型的な11−メト
キシ脂肪酸メチルエステルであることを示している。The peaks for A and B are from Shima.
zu QP-1000 (Kyoto) Mass spectrometer (Carri
er gas: subjected to GC-MS analysis by N 2).
The respective results are shown in FIGS. 2 and 3. A and B
The GC-MS analysis results of the above show that these are typical 11-methoxy fatty acid methyl esters.
【0021】[0021]
【図1】検体1のGLC分析結果を示す。FIG. 1 shows a GLC analysis result of Sample 1.
【図2】ピークAのGC−MS分析結果を示す。FIG. 2 shows the GC-MS analysis result of peak A.
【図3】ピークBのGC−MS分析結果を示す。FIG. 3 shows the GC-MS analysis result of peak B.
Claims (1)
を酸メタノリシスし、式 (式中、nは5または7である。)で表される11−メ
トキシ脂肪酸メチルエステルを同定することからなるヘ
リコバクター ピロリの検出方法。1. A sample containing Helicobacter pylori is subjected to acid methanolysis, (In the formula, n is 5 or 7.) A method for detecting Helicobacter pylori, which comprises identifying 11-methoxy fatty acid methyl ester represented by the formula.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5036661A JP2874504B2 (en) | 1993-02-25 | 1993-02-25 | How to detect Helicobacter pylori |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5036661A JP2874504B2 (en) | 1993-02-25 | 1993-02-25 | How to detect Helicobacter pylori |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH06245793A true JPH06245793A (en) | 1994-09-06 |
| JP2874504B2 JP2874504B2 (en) | 1999-03-24 |
Family
ID=12476048
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5036661A Expired - Lifetime JP2874504B2 (en) | 1993-02-25 | 1993-02-25 | How to detect Helicobacter pylori |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2874504B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996016053A1 (en) * | 1994-11-21 | 1996-05-30 | Pfizer Pharmaceuticals Inc. | Phthalide compounds and their production process |
-
1993
- 1993-02-25 JP JP5036661A patent/JP2874504B2/en not_active Expired - Lifetime
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996016053A1 (en) * | 1994-11-21 | 1996-05-30 | Pfizer Pharmaceuticals Inc. | Phthalide compounds and their production process |
| US5861518A (en) * | 1994-11-21 | 1999-01-19 | Dekker; Koenraad A. | Phthalide compounds and their production process |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2874504B2 (en) | 1999-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Calvin et al. | The path of carbon in photosynthesis. XX. The steady state | |
| Abel et al. | Classification of microorganisms by analysis of chemical composition I: feasibility of utilizing gas chromatography | |
| Burns et al. | The association of Streptococcus bovis fecal carriage and colon neoplasia: possible relationship with polyps and their premalignant potential. | |
| JP2773816B2 (en) | Methods for analyzing the presence of Chlamydia infection and species-specific antigens of Chlamydia trachomatis | |
| Braden et al. | New immunoassay in stool provides an accurate noninvasive diagnostic method for Helicobacter pylori screening in children | |
| Chinn et al. | Gas chromatography-chemical ionization mass spectrometry of cocaine and its metabolites in biological fluids | |
| Van Tassel et al. | Production of a fecal mutagen by Bacteroides spp | |
| Fujita et al. | Direct molecular mass determination of trehalose monomycolate from 11 species of mycobacteria by MALDI-TOF mass spectrometry | |
| Larsson et al. | Diagnosis of pulmonary tuberculosis by selected-ion monitoring: improved analysis of tuberculostearate in sputum using negative-ion mass spectrometry | |
| Lambert Jr et al. | Identification of Actinomyces israelii and Actinomyces naeslundii by fluorescent-antibody and agar-gel diffusion techniques | |
| Vinh et al. | Characterization and taxonomic significance of lipopolysaccharides of Leptospira interrogans serovar hardjo | |
| Beckman et al. | Immunochemical analysis of serologically active lipids of Mycoplasma pneumoniae | |
| Larsson | Gas chromatography and mass spectrometry | |
| Hunter et al. | Using high-sensitivity lipidomics to assess microscale heterogeneity in oceanic sinking particles and single phytoplankton cells | |
| Gangadoo et al. | The multiomics analyses of fecal matrix and its significance to coeliac disease gut profiling | |
| JP2874504B2 (en) | How to detect Helicobacter pylori | |
| RU2024021C1 (en) | Method of tuberculosis diagnosis | |
| CN108659059A (en) | The synthetic method of blood group antigens A and the like a kind of and application | |
| Kusaka et al. | Isolation and identification of mycolic acids in Mycobacterium leprae and Mycobacterium lepraemurium | |
| Kashima et al. | Detection of anti-cord factor antibodies in intestinal tuberculosis for its differential diagnosis from Crohn's disease and ulcerative colitis | |
| JP5265357B2 (en) | Lipid antigen detection method using mass spectrometer | |
| Muranishi et al. | Measurement of tuberculostearic acid in sputa, pleural effusions, and bronchial washings a clinical evaluation for diagnosis of pulmonary tuberculosis | |
| Cookson et al. | A qualitative and quantitative study of the cellular fatty acids of Streptococcus milleri with capillary gas chromatography | |
| IE46618B1 (en) | Peptide complexes of desoxyribonucleic acid(dna)obtained from dna-containing organisms | |
| Böhning et al. | Rapid identification of Haemophilus influenzae serovar b by gas liquid chromatography using carbohydrate fingerprints |